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BIOSYNTHESIS of LTB4during cell-cell interaction between
vascular smooth muscle cells (SMC) and alveolar
macrophages (AM) has been investigated by use of both
high-pressure Hquid chromatography (HPLC) and
radtoimmunoassay (RIA). Both interleukin-1[ (IL-1) and
tumour necrosis factor-cz (TNFcx) induced a time- and
dose-dependent synthesis of 15-, and 5-hydroxy-
eicosatetraenoic acids (HETEs) from cultured SMC. How-
ever, neither TNF nor IL-I induced a significant LTB
production in SMC alone orAM alone after 24 h of incu-
bation. Addition ofIL-I and TNFcx simultaneouslyto SMC
resulted in a dose-dependent synergistic increase of
HETEs. Macrophages dose-dependently transformed ex-
tremely low concentrations ofexogenous LTA4 into LTB
Incubation of vascular SMC with various numbers ofAM
in the presence of IL-I[ (5 units/ml) and TNFcx (10 units/
ml) induced a great increase of LTB synthesis in com-
parison with the detectable levels of LTB produced by
macrophages alone. Pretreatment of SMC with NDGA,
cycloheximide, and actinomycin not only inhibited IL-1
andTNT induced HETEs synthesis but also abolishedLTB
production when co-incubated with macrophages. These
results suggest that LTB4 in a mixture of SMC and
macrophages could originate from a transcellular me-
tabolism, i.e. macrophages transforming SMC-derived
LTA into LTB4.
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Introduction
The generation of leukotrienes (LTs) by
lipoxygenase catalysed reactions is associated with a
wide range of cell types that are involved in both
physiological and pathological events. The
transcellular metabolism of lipoxygenase derived
metabolites has recently been reported not only to
amplify the level of eicosanoids within a local milieu
but also to stimulate the generation of biologically
active metabolites with functions different from
those in its original cells. For example, the presence
of erythrocytes can greatly induce LTB formation
from neutrophil-derived LTA4; co-incubation of
endothelial cells, smooth muscle cells or platelets
with neutrophils, can result in transcellular LTC4
synthesis. Perfusion of blood free rabbit lung and
isolated pulmonary artery with neutrophils induced
an overall Lwg4, Ewe and LTD release. The transfer
of unstable metabolic intermediates has been consid-
ered to be a biochemical basis for these phenom-
ena?-5.9a0
Macrophages are well known to play a central role
in the modulation of inflammatory and immune pro-
cesses, as well as in tissue injury and repair.
1
Macrophages have 5-1ipoxygenase activity that in-
serts molecular oxygen into arachidonic acid to form
an unstable peroxide 5-HPETE leading to the genera-
tion of 5-HETE, or through the epoxide intermediate,
LTA4, to the .generation of LTB4 by hydrolase; or
conjugation with glutathione by glutathione-S-
transferase to form the cysteine LTC4, D and E4.2’1
Recently, many studies have indicated that
macrophages are a potent source of arachi-
donate metabolites generated via lipoxygenase
pathways.1-1s In vivo, SMC and macrophages have
been noted to interact at the site of thrombosis,
vessel injury and inflammation by secreting
interleukin-1 (IL-1), tumour necrosis factor (TNF),
prostaglandins (PG) and leukotrienes. 15a6 This inves-
tigation was designed to study whether or not a shift
in the metabolic profile of arachidonate products
generated by activated macrophages or vascular SMC
could be induced under circumstances that may be
related more closely to those operative inflammatory
reactions in vivo.
Materials and Methods
Reagents: Human recombinant IL-1]] and TNF0t were
obtained from Sigma (Saint Quentin Fallavier,
France). Labelled H-AA and radioactive standards
were from Amersham (Aylesbury, UK). Synthetic
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LTA4 methyl ester from Sigma was hydrolysed to
yield the free acid according to the methods de-
scribed by Maycock. 17 Octadecyl silica Sep-Pak car-
tridges were obtained from Millipore/Waters (Les
Ulis, France). Media, sera and reagents for cell cul-
tures were obtained, if not further specified, from
Gibco (Paisley, UK). All solvents used in chromato-
graphic systems were of HPLC grade.
Vascular SMC culture:. Vascular SMC cells were ob-
tained by dissociation of tissues from rat abdominal
aorta with 0.05% EDTA and 0.1% trypsin in HAM F10
medium. During the first 2 weeks, the cells were
cultured at 37C, with 5% CO,. in HAM F10 medium
supplemented with 20% foetal calf serum. When a
monolayer was obtained, the cells were removed by
trypsin-EDTA (0.05-0.02%) and cultured in 25 ml
flasks in HAM F10 medium, supplemented with 10%
foetal calf serum and 1% penicillin-streptomycin.
Culture SMC grew in typed ’hill and valley’ formation.
Cells up to the 25th passage were used for the
experiments.
Alveolar macrophage isolation and culture: Respira-
tory disease-free 125 to 150 g female Wistar rats were
housed under pathogen-free condition. Rats were
anaesthetized with i.p. sodium pentobarbital and
lungs were exercised and washed as described pre-
viously.
TM Bronchoalveolar lavage cells were 96% AM
by microscopic examination of cytocentrifuge prepa-
rations stained with a modified Wright-Giemsa stain
(Diff-Qick, American Scientific Products, IL).
Bronchoalveolar cells (5 x 106) suspended in 10 ml of
M199 were plated in 25 ml flasks and cultured at 37C
in a humidified atmosphere of 5% CO,. in air. After
2 h, nonadherent cells were removed by washing
twice with the medium. Cell monolayers were then
cultured in M199 containing 10% heat inactivated
newborn calf serum before experimental incubation.
3H-arachidonic acid metabolism in macrophages
and SMC: Monolayer vascular SMC cells (5 x 106) or
macrophages (5 xl06) were plated in a fresh culture
medium. The cells were incubated with 1 btM 3H-AA
for 18 h and then the medium was harvested. The
cells were washed three times with PBS containing
0.25% fatty acid free bovine serum albumin (BSA) to
eliminate non-incorporated AA. These cells were
covered with 7 ml of serum free medium. IL-1]]
(5 units/ml) and TNF (10 units/ml) were added
and the cells were incubated at 37C for 24 h. Then
the culture medium was harvested and centrifuged.
The supernatants were stored at-80C for eicosa-
noid assay.
Co-culture ofmacrophages and SMC: Biosynthesis of
gWB during cell-cell interaction was studied by incu-
bating fixed concentrations of H-AA labelled SMC
with various numbers of alveolar macrophages. For
co-culture experiments, H-labelled SMC (5x 106
cells) were further incubated with macrophages in
the presence of IL-113 (5 units/ml) and TNF (10
units/ml) at 37C for 24 h following the ratios of SMC
to macrophages: SMC alone, 100:1, 10:1, 1:1, 1:10,
1:100, macrophages alone, and macrophages alone
but in the presence of IL-I and TNF. After the
incubation, the supernatants were collected, centri-
fuged and stored at-80C until eicosanoid assay.
Transformation of lra4 by macrophages:
Macrophages (lx 106 cells) in 35 mm wells were
allowed to equilibrate for 5 min at 37C in 1 ml
HBSS/BSA and then incubated at 37C for 15 min
with LTA4 at concentrations described in the figure
legends. At the end of the incubation, 1 ml of ice-
cold methanol was added and the medium was
harvested, centrifuged and kept at-20C for analysis
by RIA for LTB4.
HPLC analysis: The HPLC system utilized was from
Waters associated (Milford, MA) using two pumps
(6000A and 510) coupled to a Model 680 gradient
controller. UV absorbance of the eluate was moni-
tored using two serial detectors. Radioactivity was
determined by mixing 1 ml of the effluent with 5-10
ml of Atomlight (NEN) and counting in a liquid
scintillating counter.
The procedure used for the precolumn extraction/
RP-HPLC of the supernatant was similar to that
described previously,19 with the six-port valve in the
’load’ position. The sample, diluted to a total volume
of 10 ml, was applied to a C8 reverse-phase guard
column (Nucleosil C, 10 l.tm, 10 mm, Macherey
Nagal) located in the sample loop of the six-port
switching valve (Rheodyne) which had been equili-
brated with solvent A (2.5 mH H3PO in 15% metha-
nol). A 3 btm filter was placed between the outlet of
the pump and the six-port valve. The precolumn was
then washed with 8 ml of solvent A. The AA
metabolites, remaining on the precolumn, were in-
jected by turning the six-port valve to the ’inject’
position onto a Spherisorb ODS2 (5 btm, 4.6 x 150
mm) column (phase separation). RP-HPLC was car-
ried out using a mobile phase consisting of a non-
linear gradient starting with 30% solvent B (water/
acetic acid 0.05, v/v, buffered to pH 5.7 with ammo-
nium hydroxide) leading to 100% solvent C (65%
acetonitrile-35% methanol) with the following pro-
gram: 0-10 min, linear to 65%; 10-35 min, linear to
100% C; 35-55 min, linear to 30% C and isocratic until
70 min. The flow rate was 1 ml/min. Under these
conditions, retention times (in min) of eicosanoids
were as follows: 20-COOH-LTB4, 5-6; 20-OH-LTB4,
11.5; LTC4, 18; A6-trans-LTB4, 21.5; LTB4, 22.5; 11-
HETE, 23.5; 15-HETE, 24.5; 12-HETE, 38.5; 5-HETE,
40; arachidonic acid, 57.1.
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Radioimmunoassay ofLTB4: The samples, acidified
to pH 3.5, were extracted with Waters Sep-Pak C18
(Milford, MA). Eicosanoids were eluted with metha-
nol (5 ml). The solvent was pooled and evaporated
to dryness under nitrogen. The residue was then
dissolved in PBS for RIA assay. The detection limit of
the radioimmunoassay for LTB was 4 pg/ml.
Results
Induction ofHETE synthesis in SMC by IL-1 and TNF:
Adherent rat vascular SMC, prelabelled with 3H-AA,
were exposed to IL-I (5 units/ml) or TNF0t (10
units/ml) for 24 h. Following this incubation, the
media were collected and then analysed by HPLC as
described in Materials and Methods. As shown in Fig.
1, both IL-li] and TNF0t induced a significant increase
of lipoxygenase metabolites. These compounds
eluted from an RP-HPLC column with retention
times that corresponded to 15- and 5-HETE, and
represented 10.9 + 2.1% and 3.8 + 0.9%, respectively,
of the total radioactivity applied to the column.
However, neither IL-1 nor TNF induced LTB produc-
tion. IL-11] or TNF(x induced lipoxygenase metabolite
formation in a dose-dependent manner (Fig. 1). The
release of HETEs in response to IL-I or TNF(x,
reached a plateau of release at concentrations above
100 units/ml. In comparison to the control, the
amounts of HETEs in SMC treated with IL-I or TNF
were enhanced 6-fold and 4-fold, respectively. In all
cases, the release of HETEs in response to IL-11]
was significantly greater than that induced by TNF0t
(Fig. 2).
The response to IL-1 or TNF was also time-depend-
ent having a lag phase of 8 h before significant
generation of HETEs in both cases (Fig. 2).
The simultaneous addition of IL-1I] and TNF0t
stimulated HETE release to a greater extent than did
either agent alone (Fig. 2). The effect was additive
and the sum of the HETEs released by both IL-1 I] and
TNF always exceeded the amount of HETEs gener-
ated after separate addition of IL-11] or TNF0 to SMC.
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FIG. 1. The dose effects of IL-11 or TNF(x on the production of
monohydroxylated compound (HETE) in rat vascular smooth muscle cells.
Results are expressed as dpm/10 cells. The values are the mean :t: S.E.M.
of five separate experiments. --, IL-1; TNF.
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FIG. 2. The time course of monohydroxylated compound (HETE) produc-
tion in rat vascular smooth vascular cells in response to IL-11 (5 units/ml),
TNF (10 units/ml), or IL-11 and TNF. Results are expressed as dpm/lO
cells and represent the mean + 8.E.M. of five separate experiments.
IL-1 + TNF; ---, IL-1 alone;, TNF alone.
In addition, preincubation of SMC with NDGA
(10-5 M) inhibited recovery of HETEs induced by
IL-li] and TNF0t (90% and 95% inhibition for IL-1 and
TNF, respectively). Metyrapone (10 to 10-4 M), a
cytochrome P450 inhibitor, did not modify the recov-
ery of monohydroxylated compounds. The protein
synthesis inhibitors cycloheximide (10-5 M) and
actinomycin (10-s M) also abolished HETEs produc-
tion induced by IL-1 and TNF. In contrast,
pretreatment of cells with aspirin (10-
to 10-5 M)
inhibited the synthesis of cyclooxygenase
metabolites (20 to 90%) and slightly increased HETEs
recovery (Table 1).
in contrast to the augmentation of AA metabolites
in SMC, incubation of macrophages with IL-11] (5
units/ml) or TNF(x (5 units/ml) did not result in
significant synthesis of IL,TB (2.7 _+ 0.5 pmol/10 cells)
although the levels obtained from stimulated cells
were higher than those obtained from unstimulated
cells (2.5 + 0.4 pmol/10 cells).
Incubation of macrophages with LTA4: In order to
synthesize IL,TB4 from the small amounts of LTA4
generated from adjacent cells, macrophages must be
Table 1. Effect of aspirin, NDGA, cycloheximide and actinomycin
on the formation of monohydroxylated compounds in IL-1 and TNF
stimulated rat vascular smooth muscle cells
Sample Monohydroxylated compounds (dpm/106 cells)
IL-1 TNF IL-1 + TNF
Control 1201 __
215 570 + 127 2370 +/- 469
Aspirin 1375 + 271 613 +/- 136 2643 + 437
NDGA 126 + 21 103 +/- 23 129 + 47
Metyrapone 1172 +/- 175 535 +/- 139 2145 +/- 513
Cycloheximide 235 +/- 57 175 +/- 27 376 +/- 53
Actinomycin 269 + 36 196 __. 39 257 +/- 27
Adherent smooth muscle cells (5x 106 cells) were incubated with
IL-11 (5 units/ml) or/and TNF (10 units/ml) for 24 h after
preincubation with aspirin (10-s M), NDGA (10-s M), cycloheximide
(10-s M) and actinomycin (10-s M) for h. The whole incubation
mixture was extracted and analysed by HPLC as described in
Materials and Methods. Results are expressed as mean +/- S.E.M.
from five experiments.
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FIG. 3. Transformation of various concentrations of LTA into LTB by
macrophages. Macrophages (lx 106 cells) in 35 mm wells with ml of
buffer were incubated at 37C for 15 min in HBSS/BSA (4 g/I) with various
concentrations of LTA4 described in the legends. The samples were then
analysed for LTB, by radioimmunoassay. Results represent the mean _+
S.E.M. of six separate experiments. --, AM present; AM absent.
capable of converting exogenous supplies of LTA4
into LTB4. The ability of macrophages to utilize
exogenous LTA was examined by incubating
macrophages (lx 106 cells) with exogenously added
LTA4. As shown in Fig. 3, macrophages were able to
transform, in dose-dependent manner, extremely
low concentrations of LTA into LTB4, but the amount
of LTB4 formed from the exogenous LTA4 (1 to 10 000
pmol) in the absence of AM but in the presence of
HBSS/BAS remained very low (5.6 to 10 pmol, as
shown in Fig. 3). This finding suggested that
transcellular synthesis of LTB4 could occur when very
limited amounts of LTA4 were available to these cells.
Transcellular LTB synthesis in the co-culture of
macrophages and SMC: Biosynthesis of LTB during
cell-cell interaction was studied using co-incubation
of SMC and macrophages in the presence of IL-I[ or
TNF(x. As shown in Figs 4 and 5, incubation of SMC
with various ratios of macrophages (100:1, 10:1, 1:1,
1:10, 1:00 and 1:1 000, SMC alone) resulted in signifi-
cant amounts of LTB in the supernatants. LTB levels
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FIG. 5. (A) Reverse phase HPLC separation of lipoxygenase products in
co-culture mixture ’as detected by UV absorption at 235 nm. (B)
Radiochromatogram of metabolites derived from aH-arachidonic acid gen-
erated in co-culture mixture as detected by HPLC. Rat vascular smooth
muscle cells (5x 106) were incubated with alveolar macrophages (5x 10) in
the presence of IL-I (5 units/ml) and TNF (10 units/ml) for 24 h. The
experimental procedures were described in Materials and Methods.
were 14.7_+ 2.5, 34.9-+ 6.7, 17.8_+ 4.3, 12.6_+ 2.9,
6.7 +_ 2.7 and 2.4 + 0.8 pmol/106 cells respectively. In
addition, the preincubation of SMC with NDGA
(10 I.tM), cycloheximide (10 btM), and actinomycin
(10 l.tM) abolished LWB production induced by IL-1
and TNF, when co-incubated with macrophages
(Table 2). However, no LTB was found when IL-1-
and TNF-treated SMC were co-incubated with NDGA
pretreated macrophages.
Discussion
50-
40-
3o
lO
$2 S3 S4 ml m2 m3 m4
FIG. 4. The production of leukotriene B in co-culture of macrophages and
vascular smooth muscle cells (SMC) in the presence of IL-I (5 units/ml)
and TNF (10 units/ml). $1, $2, $3 and $4 represent the various ratios of
SMC to macrophages (SMC alone, 100:1, 10:1, 1:1 respectively). M 1, M2,
M3 and M4 represent the various ratios of macrophages to SMC
(macrophages alone, and macrophages in the presence of IL.I and TNF,
100:1, 10:1 respectively). The experimental procedure is described in
Materials and Methods. Results are the mean + S.E.M. of six Separate
experiments. *p < 0.05, **p < 0.01 (Student’s paired t-test).
In this study, the transcellular synthesis of LTB4
during cell-cell interaction between IL-I[ and TNF(x
activated vascular SMC and macrophages has been
Table 2. Effect of aspirin, NDGA, cycloheximide and actinomycin
on LTB formation in co-culture of macrophages with IL-1 and TNF
stimulated rat vascular muscle smooth cells
Sample LTB4 (pmol/106 cells)
IL-1 34.9 + 6.7
Aspirin + IL-1 37.2 +_ 5.9
NDGA + IL-1 4.7 + 1.7
Cycloheximide + IL-1 4.9 + 2.5
Actinomycin + IL-1 4.7 + 2.1
Adherent smooth muscle cells (5x 106 cells) were incubated with
5x 10 macrophages in the presence of IL-1 (5 units/ml) and TNF
(10 units/ml) for 24 h after preincubation with aspirin (10-s M),
NDGA (10-s M), cycloheximide (10-s M) and actinomycin (10-s M)
for h. The whole incubation mixture was extracted and analysed
by HPLC as described in Materials and Methods. Results are
expressed as mean _+ S.E.M. from five experiments
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demonstrated for the first time. The incubation of
individual SMC with IL-I or TNF0t did not produce
LTB4. Neither IL-I[ or TNFct induced significant LTB
production in macrophages incubated at 37C for
24 h. However, using co-culture of SMC with various
ratios of macrophages in the presence of IL-I and
TNFtx, it was found that levels of LTB were greatly
increased compared with macrophages alone.
In accordance with previous reports on rabbit
chrondrocytes,’ rheumatoid synovial cells,
21 and
human glomerular mesengial cells,
22 both IL-1I and
TNFct induced a dose- and time-dependent forma-
tion of eicosanoids. The amount of HETEs was sig-
nificantl greater than the additive effects of the two
cytokines alone. The mechanism by which IL-l[5 and
TNF0t activated the HETEs synthesis is not known.
Many reports have indicated that IL-ll and TNFct
cause an up-regulation of phospholipase A2 and
cyclooxygenase-2, which, unlike cyclooxygenase-1,
metabolize arachidonic acid not only to
prostaglandins but also to a significant extent to
11-, 15- and 5-HETE. 2’23’24 The increase of HETE
synthesis in SMC cells might also be due to the
increase of enzyme protein synthesis, such as
cyclooxygenase and/or phospholipase A,. in. IL-115 or
TNFtx stimulated cells because cycloheximide, a pro-
tein inhibitor, inhibited HETE increase induced by IL-
1[ and TNFct in SMC, but the mechanism remains to
be elucidated.
The synthesis of LTB involves a complex series of
reactions within macrophages. A limiting factor for
LTB biosynthesis was found to be the availability of
the unstable intermediate, LTA4. However, the gen-
eration of LTA4 depends upon activation of 5-
lipoxygenase as well as the presence of its substrate,
arachidonic acid. ’5 The production of LTs by human
polymorphonuclear leukocytes has been known to
be significantly influenced by adjacent cells possess-
ing distinctly different metabolic properties. ’-5 In this
study, macrophages transformed very low concentra-
tions of exogenous LTA4 into LTB4 suggesting that
macrophages could metabolize LTA4 into biologically
active LTB4. The co-culture ofSMC with various ratios
of macrophages greatly increased LTB synthesis
when compared with very low levels of gwg pro-
duced by individual cells. The highest augmentation
in gWB was obtained when the ratio of SMC to
macrophages was 10:1. Because IL-ll and TNFo: did
not induce a significant LTB production either in
SMC alone or in macrophages alone, and because the
pretreatment of SMC cells and macrophages with the
lipoxygenase inhibitor NDGA and protein synthesis
inhibitors, blocked LTB formation, it could be con-
cluded that cell-cell interaction could be responsible
for this augmentation, i.e. macrophages utilizing
SMC-derived LTA or its precursor, 5-HPETE for its
syn-thesis of LTB during co-incubation of SMC and
macrophages. According to the cell cooperation
classification of Marcus, LTB biosynthesis could
come from the interaction of type IA (cells can share
a common precursor synthesized by different cells).24
However, the mechanism of LTB4 transcellular
synthesis is certainly more complex. Irvine25 has
demonstrated that arachidonic acid availability is a
major limiting factor for LTs synthesis. Furthermore,
several studies have suggested that a transfer of
arachidonic acid takes place in in vitro cell-cell
cooperation such as during platelet-neutrophil inter-
action.8,m,5,26 For example, Palmentier and Borgeat
have presented evidence that thrombin activated
platelets offer free arachidonic acid to neutrophils
that are utilized for LTB4 synthesis. Antoine et al.
have also found that neutrophils can utilize platelet-
derived arachidonic acid for the formation of the 5-
lipoxygenase product. Therefore, the possibility that
other mechanisms are responsible for LTB synthesis
cannot be excluded from the present data.
The transcellular synthesis of l,WB between
vascular SMC and macrophages may have an
important physiological and pathophysiological
significance. The lipoxygenase products of AA
metabolism are involved in various aspects of
inflammation and atherosclerotic lesions. ’7 For
example, the intimal accumulation of smooth muscle
cells in rabbit carotid arteries, an early stage of
atherosclerosis, is inhibited by dexamethasone,
which prevents formation of both cyclooxygenase
and lipoxygenase metabolites, but is not inhibited by
nonsteroidal anti-inflammatory drugs such as
indomethacin. ’,’9 The transcellular LTB synthesis
could be involved in the genesis of atherosclerosis
and other vascular diseases because of its action of
initiating vascular inflammation, promoting vascular
constriction and proliferation as well as platelet
aggregation.
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